Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Cohort 1: hATG, CsA, EPAG Day 14 to Month 6[1] Antilymphocyte immunoglobulin (horse)---[1] 60
2Cohort 2: hATG, CsA, EPAG Day 14 to Month 3[1] Antilymphocyte immunoglobulin (horse)---[1] 60
3Cohort 3: hATG, CsA (dose reduced), EPAG day 1 to month 6[1] Antilymphocyte immunoglobulin (horse)---[1] 60
4EPA----[6] 8, 46, 48, 49, 113, 301
5EPA and DHA----[1] 113
6EPA and DHA supplementation----[2] 48, 49
7Epadel----[1] 296
8Epanova[1] Omega-3-carboxylic acids (Synonym: Epanova)---[1] 96
9Epanova™ (Omega-3 Free Fatty Acids)[1] Omega-3 fatty acids---[1] 96
10EPARMEFOLIN 30 CPR 0,1/0,5MG----[1] 13
11Epatuzumab----[1] 49
12EPAX 6000 EE 1000mg (0.6 gr DHA+EPA)----[1] 46
13Epaxal----[1] 46
14Epaxal Berna (virosomal hepatitis A vaccine)[1] Hepatitis A Vaccine (Synonym: Epaxal)---[2] 96, 97
15Ethyl-EPA[1] Icosapent ethyl (Synonym: Ethyl-EPA)[1] D01892 (Name: Epadel S (TN))--[1] 8
16Ethyl-EPA (Miraxion™)[1] Icosapent ethyl (Synonym: Ethyl-EPA)[1] D01892 (Name: Epadel S (TN))--[1] 8
17Hepatitis A vaccine ( HAVRIX or EPAXAL)[1] Hepatitis A Vaccine (Synonym: Epaxal)---[1] 46
18Over the counter DHA/EPA dietary supplementation----[1] 301